Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs

IMPORTANCE: In many health systems, access to off-label drug use is controlled through reimbursement restrictions by health insurers, especially for expensive cancer drugs. OBJECTIVE: To determine whether evidence from randomized clinical trials is associated with reimbursement decisions for request...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Netw Open
Главные авторы: Herbrand, Amanda Katherina, Schmitt, Andreas M., Briel, Matthias, Ewald, Hannah, Goldkuhle, Marius, Diem, Stefan, Hoogkamer, Anouk, Joerger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars G., Kasenda, Benjamin
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2021
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7926292/
https://ncbi.nlm.nih.gov/pubmed/33651108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.0380
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы